<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136189">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01918280</url>
  </required_header>
  <id_info>
    <org_study_id>2009.576</org_study_id>
    <nct_id>NCT01918280</nct_id>
  </id_info>
  <brief_title>Fertility Preservation in Cases of Klinefelter Syndrome.</brief_title>
  <acronym>FERTIPRESERVE</acronym>
  <official_title>Fertility Preservation in Cases of Spermatogenesis Failure : Prospective Study for Klinefelter Syndrome With Non-mosaic Karyotype (47, XXY, Homogeneous)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Klinefelter Syndrome (KS) is the most common sex chromosomal abnormalities (1/600 newborn
      males), and is characterized by a hypergonadism hypogonadism. Until few years ago, mostly
      non-mosaic KS was considered as a model of a complete male infertility although few KS
      (4-8%) have an oligospermia. Recent studies in adult with non-mosaic KS reported the
      possibility of sperm retrieval by testicular biopsy (TESE) in around 50% cases and more than
      some pregnancies have been obtained after TESE with Intracytoplasmic Sperm Injection (ICSI).
      Since 1997, more than one hundred births are described.

      As some studies shown a decrease of successful sperm retrieval with the increasing of age,
      we plan to compare the potential of sperm retrieval between two groups &quot;adult&quot; (23-55 years)
      and &quot;young&quot; after the onset of puberty (15-22 years). The study will be performed by
      searching spermatozoa on two seminal analyses spaced out 3 months followed by a testicular
      biopsy if the azoospermia is confirmed on semen analyses.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>TEsticular Sperm Extraction (TESE)</measure>
    <time_frame>15 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Improvement of sperm retrieval rate by Testicular Sperm extraction (TESE) in the &quot;Young&quot; group compare to &quot;Adult&quot; group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Androgenotherapy</measure>
    <time_frame>15 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Influence of antecedent of androgenotherapy before Testicular Sperm extraction (TESE) : treatment or not, duration of treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognosis factors</measure>
    <time_frame>15 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Identification of prognosis factors of sperm retrieval (by TESE) in the two groups &quot;Young&quot; and &quot;Adult&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histopathologist analyses</measure>
    <time_frame>15 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Histopathologist analyses of testicular biopsy in the two groups &quot;Young&quot; and &quot;Adult&quot;. In the 2 groups, comparison of cases with and without sperm.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Klinefelter Syndrome</condition>
  <arm_group>
    <arm_group_label>Young group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15-22 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adult group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>23-55 years</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Seminal analyses and testicular biopsy</intervention_name>
    <description>Two seminal analyses spaced out 3 months followed by a testicular biopsy if the azoospermia is confirmed on semen analyses.</description>
    <arm_group_label>Young group</arm_group_label>
    <arm_group_label>Adult group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Klinefelter Syndrome with 47,XXY non-mosaic

          -  Androgenotherapy stopped since more than 6 months

        Exclusion Criteria:

          -  Antecedent of Radiotherapy or chemotherapy

          -  Psychological trouble

          -  Treatment interfering with spermatogenesis

          -  Androgenotherapy non stopped
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingrid PLOTTON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ingrid PLOTTON, MD</last_name>
    <phone>472 12 96 81</phone>
    <phone_ext>+33</phone_ext>
    <email>ingrid.plotton@chu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service d'Endocrinologie Moléculaire et Maladies Rares, Centre de Biologie Est, Hospices Civils de Lyon</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingrid PLOTTON, MD</last_name>
      <phone>472 12 96 81</phone>
      <phone_ext>+33</phone_ext>
      <email>ingrid.plotton@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Ingrid PLOTTON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 15, 2014</lastchanged_date>
  <firstreceived_date>August 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Klinefelter Syndrome</keyword>
  <keyword>Azoospermia</keyword>
  <keyword>Seminal analyses</keyword>
  <keyword>Testicular biopsy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Klinefelter Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
